MedPath

Zavedos

Brand Name: Zavedos

Generic Name: Idarubicin Hydrochloride

Active
Registration Number

DR-XY15884

Dosage Form

Lyophilized Powder for IV Injection

Issuance Date

July 31, 2023

Expiry Date

July 31, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5 mg
Packaging10 mL-Capacity Type I Colorless Glass Vial with Chlorobutyl Rubber Stopper and Aluminum Seal with Polypropylene Flip-off Top (Box of 1's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antineoplastic (Anthracycline and related substance)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Idarubicin HydrochlorideActive
Monograph: Idarubicin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform